According to the World Health Organization (WHO), Pharmacovigilance is defined as the science and activities related to the detection, evaluation, understanding and prevention of adverse events or any other safety related situations with the products.
Responsibility for ensuring safety in the use of medicines belongs to everyone: industries, regulatory agencies, health professionals and patients. Therefore, when you become aware of an adverse event by a patient under treatment with a Cellera Farma drug, we advise you to contact us using the form below, or contact our team of pharmacists by phone:
Monday through Friday
From 8:30 a.m. to 4:00 p.m.
(except on holidays)
According to ANVISA (RDC 04/09), an adverse event is any medical occurrence, which may occur during treatment with a medicine, but that doesn’t necessarily have a causal relationship to that treatment
Therefore, an adverse event is considered:
Reaction to a drug that is harmful and unintentional and that occurs at doses normally used in humans for prophylaxis, diagnosis, therapy of the disease or for the modification of physiological functions.
Any unfavorable medical occurrence that may occur during treatment with a drug associated with a technical claim involving such drug (e.g. changes in color, odor, taste).
Use not described in the lable (“off label”): It encompasses the use in situations other than the recommended in the package insert of a drug registered with Anvisa. It may include differences in indication, age range / weight, dose, frenquency, presentation or route of administration.
Important notice: We do not issue any medical opinion regarding health matters, which should be done by doctor of confidence